John Mendlein

(Dr. John Mendlein Ph.D.)

Currently holds positions in aTyr Pharma Inc and Fate Therapeutics Inc

Positions

Position Company Period
Director aTyr Pharma Inc Nov. 1, 2017 -
Vice Chairman of the Board Fate Therapeutics Inc Jan. 1, 2017 -
Independent Director Editas Medicine Inc Jan. 1, 2016 - March 27, 2018
Chief Executive Officer, Director aTyr Pharma Inc Dec. 1, 2015 - Nov. 1, 2017
Vice Chairman of the Board Fate Therapeutics Inc None -
Chief Executive Officer and Executive Chairman, Board of Directors aTyr Pharma Inc Sept. 1, 2011 - Dec. 1, 2015
John Mendlein's trades of Fate Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-13 2023-01-13
B Purchase
36,631 +14.9%
5.43
USD 198,906 		36,631 +14.9% 5.43 USD 198,906
2023-01-13 2023-01-11
B Purchase
88,048 +55.7%
5.67
USD 499,232 		88,048 +55.7% 5.67 USD 499,232
2022-06-06 2022-06-03
S Sale
1,364 -0.9%
22.79
USD 31,086 		1,364 -0.9% 22.79 USD 31,086
2022-03-11 2022-03-10
PS Planned sale
12,069 -7.0%
35.48
USD 428,208 		12,069 -7.0% 35.48 USD 428,208
2022-03-11 2022-03-10
PS Planned sale
19,493 -10.2%
34.73
USD 676,992 		19,493 -10.2% 34.73 USD 676,992
// ... existing code ... // ... rest of the file ...